Aristeia Capital’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-11,863
Closed -$199K – 951
2026
Q2
$199K Sell
11,863
-12,118
-51% -$170K ﹤0.01% 560
2026
Q1
$286K Buy
+23,981
New +$344K 0.01% 435
2025
Q4
– Sell
-11,645
Closed -$252K – 689
2025
Q3
$252K Sell
11,645
-103
-0.9% -$2.3K 0.01% 359
2025
Q2
$261K Buy
+11,748
New +$261K 0.01% 325

Other funds holding SGRY

Aristeia Capital's SGRY Position: Q3 2026 in Review

Aristeia Capital sold out of Surgery Partners (SGRY) in Q3 2026, closing a stake of 11,863 shares — an estimated $199K sold.

Aristeia Capital first reported a position in SGRY in Q2 2025 and held it in 4 quarters. The position peaked at $286K in Q1 2026. 191 funds tracked by Wall St. Rank hold SGRY as of Q3 2026.

  • Aristeia Capital reported no remaining Surgery Partners position as of Q3 2026 after selling out during the quarter.
  • Aristeia Capital sold 11,863 Surgery Partners shares in Q3 2026, an estimated $199K.
  • Aristeia Capital first reported a position in Surgery Partners in Q2 2025 and held it in 4 quarters.
  • Aristeia Capital's Surgery Partners position peaked at $286K in Q1 2026.
  • 191 funds tracked by Wall St. Rank held Surgery Partners as of Q3 2026.

Based on Aristeia Capital's 13F filing for Q3 2026, filed 16 Nov 2026.